SCHEMBL25540965

SCHEMBL25540965

Clc1cc(-c2ccccc2-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.58
ATP4A P20648 1/20 0.49
ATP4B P51164 1/20 0.49
HSP90AA1 P07900 3/20 0.49
HSP90AB1 P08238 3/20 0.49
KDM4E B2RXH2 1/20 0.49
POLB P06746 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
MAPT P10636 2/20 0.45
MCOLN3 Q8TDD5 1/20 0.45
GPR55 Q9Y2T6 1/20 0.44
HTT P42858 1/20 0.44
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30582646 1.00 LMNA (0.58) LMNAATP4AATP4BHSP90AA1HSP90AB1
SCHEMBL26626348 0.93 HSP90AA1 (0.49) LMNAATP4AATP4BHSP90AA1HSP90AB1
SCHEMBL30601310 0.93 HSP90AA1 (0.49) LMNAATP4AATP4BHSP90AA1HSP90AB1
SCHEMBL38655879 0.87 HSP90AA1 (0.62) LMNAATP4AATP4BHSP90AA1HSP90AB1
SCHEMBL25649590 0.86 LMNA (0.54) LMNAATP4AATP4BHSP90AA1HSP90AB1
SCHEMBL22084208 0.85 ALDH1A1 (0.57) LMNAATP4AATP4BHSP90AA1HSP90AB1
SCHEMBL31643196 0.85 KDM4E (0.58) LMNAATP4AATP4BHSP90AA1HSP90AB1
SCHEMBL15840233 0.84 LMNA (0.62) LMNAATP4AATP4BHSP90AA1HSP90AB1
SCHEMBL423874 0.84 KDM4E (0.66) LMNAATP4AATP4BHSP90AA1HSP90AB1
SCHEMBL17412397 0.84 KDM4E (0.44) LMNAHSP90AA1HSP90AB1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM LMNA 2202/4885ATP4A 2446/4885ATP4B 2111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.